SASP can reduce oxidative stress and the inflammatory response in TNBS-induced colitis model rats by reducing the expression of TNF-α and IL-1β and inhibiting IL-6/JAK2/STAT3 signal transduction (Elhefnawy et al., 2023). The gene discussed is IL1B; the disease is colitis.